|
Objective: This study is the application Ginkgo biloba Injection and Shuxuening of clinical control through statistical analysis , to further clarify the ginkgo leaf injection the meridian stroke ( cerebral infarction ) stasis stasis of the safety and efficacy of the certificate , and the effectiveness of the apoplexy individual symptoms and TCM climate . Methods: This study randomized , blinded , positive control . Divided into experimental group ( Ginkgo biloba L. ) and the control group ( Shu Xue Ning injection ) were observed apoplexy meridian ( cerebral infarction) the blood stasis card cases to 60 cases , 45 cases of the test group ( Ginkgo biloba injection group of 45 patients ) in the control group ( 15 cases ) Shuxuening . Results: The treatment group drug ginkgo biloba injection control group drug Shuxuening injection made ??basically the same effect ( P > 0.05 ) , upper and lower extremity muscle strength, walking ability in raising awareness, level gaze , facial paralysis , injection of Ginkgo biloba can improve the symptoms of patients with neurological deficits . Improving TCM syndrome , the treatment group drug - drug than the control group , especially in improving the numbness and headache was significantly better than the control group ( P <0.05 ) . Conclusion: Ginkgo biloba injection can improve symptoms of patients with cerebral infarction (stroke, blood stasis card ) neurological deficit , its good clinical effects were observed , no significant side effects and adverse reactions ; evident in to improve numbness and headache two effect.
|